Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction

J Am Coll Cardiol. 2023 Mar 14;81(10):1004-1006. doi: 10.1016/j.jacc.2022.12.026.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Heart Failure* / drug therapy
  • Heart Failure* / epidemiology
  • Hospitalization*
  • Humans
  • Stroke Volume
  • Ventricular Function, Left

Substances

  • dapagliflozin
  • Benzhydryl Compounds

Associated data

  • ClinicalTrials.gov/NCT03619213